【结 构 式】 |
【分子编号】35329 【品名】2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-(benzyloxy)propyl propionate 【CA登记号】 |
【 分 子 式 】C19H23N5O5 【 分 子 量 】401.42232 【元素组成】C 56.85% H 5.78% N 17.45% O 19.93% |
合成路线1
该中间体在本合成路线中的序号:(XXV)The condensation of 1-acetoxy-2-(acetoxymethoxy)-3-(benzyloxy) propane (XXI) with guanine (XXII) by means of HMDS and trifluoromethanesulfonic acid gives O-acetyl-O'-benzylganciclovir (XXIII), which is deacetylated with NaOH in methanol to yield the previously reported mono-O-benzylganciclovir (XVIII). The preceding reaction sequence can also be performed by using 1-(benzyloxy)-2-(propionyloxymethoxy)-3-(propionyloxy)propane (XXIV) instead of compound (XXI), yielding intermediate (XXV) and finally the previously reported mono-O-benzylganciclovir (XVIII).
【1】 Sorbera, L.A.; Castañer, J.; Castañer, R.M.; Valganciclovir Hydrochloride. Drugs Fut 2000, 25, 5, 474. |
【2】 Dvorak, C.A.; Beard, C.C.; Wren, D.L.; Axt, S.D.; Han, Y.-K.; Fatheree, P.R.; Nguyen, S.L.; Lund, J.P.; Fisher, L.E.; Arzeno, H.B.; Humphreys, E.R. (F. Hoffmann-La Roche AG); Process for preparing purine derivs.. US 6040446; WO 9727198 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XVIII) | 35324 | 2-amino-9-[[2-(benzyloxy)-1-(hydroxymethyl)ethoxy]methyl]-1,9-dihydro-6H-purin-6-one | C16H19N5O4 | 详情 | 详情 | |
(XXI) | 35326 | [2-(acetoxy)-1-[(benzyloxy)methyl]ethoxy]methyl acetate | C15H20O6 | 详情 | 详情 | |
(XXII) | 10352 | 2-Amino-1,9-dihydro-6H-purin-6-one; Guanine | 73-40-5 | C5H5N5O | 详情 | 详情 |
(XXIII) | 35327 | 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-(benzyloxy)propyl acetate | C18H21N5O5 | 详情 | 详情 | |
(XXIV) | 35328 | 3-(benzyloxy)-2-[(propionyloxy)methoxy]propyl propionate | C17H24O6 | 详情 | 详情 | |
(XXV) | 35329 | 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-(benzyloxy)propyl propionate | C19H23N5O5 | 详情 | 详情 |